Cargando…
Does anthracycline-based chemotherapy in pregnant women with cancer offer safe cardiac and neurodevelopmental outcomes for the developing fetus?
BACKGROUND: Cancer treatment during pregnancy is a growing problem especially now that women delay childbearing. Systemic treatment of these malignancies during pregnancy centers mainly on the anticancer drugs anthracyclines, widely used in treating hematological and breast cancer during pregnancy a...
Autores principales: | Framarino-dei-Malatesta, Marialuisa, Sammartino, Paolo, Napoli, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696726/ https://www.ncbi.nlm.nih.gov/pubmed/29162041 http://dx.doi.org/10.1186/s12885-017-3772-9 |
Ejemplares similares
-
Breast cancer or metastasis? An unusual case of metastatic malignant pleural mesothelioma to the breast
por: Framarino-dei-Malatesta, Marialuisa, et al.
Publicado: (2015) -
Epirubicin: a new entry in the list of fetal cardiotoxic drugs? Intrauterine death of one fetus in a twin pregnancy. Case report and review of literature
por: Framarino-dei-Malatesta, Marialuisa, et al.
Publicado: (2015) -
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer
por: Cornali, Tommaso, et al.
Publicado: (2017) -
COVID-19 in a pregnant kidney transplant recipient - what we need to know: A case report
por: Angelico, Roberta, et al.
Publicado: (2022) -
Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice
por: Kent, Julie, et al.
Publicado: (2014)